Outcomes of thyroid cancer in African Americans

Ethnicity and Disease

Volumn 21, Issue 2, 2011, Pages 210-215

  Hollenbeak, Christopher S ^a   Wang, Li ^a   Schneider, Patrick ^a   Goldenberg, David ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

African Americans; Anaplastic; Caucasians; Follicular thyroid cancer; Papillary; Racial disparities; Thyroid cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; ANAPLASTIC CARCINOMA; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHI SQUARE TEST; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; STUDENT T TEST; SURVIVAL RATE; THYROID CARCINOMA; UNIVARIATE ANALYSIS; ETHNOLOGY; HEALTH DISPARITY; MIDDLE AGED; MORTALITY; PATHOLOGY; STATISTICS; THYROID TUMOR; TREATMENT OUTCOME; UNITED STATES;

ADULT; AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; THYROID NEOPLASMS; TREATMENT OUTCOME; UNITED STATES;

EID: 80053338229     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. National Cancer Institute. Thyroid Cancer. http://www.cancer.gov/ cancertopics/types/thyroid. Last accessed July 22, 2010.
2. Mitchell I, Livingston EH, Chang AY, et al. Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery. 2007;142(6):823-828; discussion 828 e821.
3. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007;142(6):906-913; discussion 913 e901-902.
4. Morris LG, Sikora AG, Myssiorek D, De- Lacure MD. The basis of racial differences in the incidence of thyroid cancer. Ann Surg Oncol. 2008;15(4):1169-1176.
5. Shaha A. Treatment of thyroid cancer based on risk groups. J SurgOncol. 2006;94(8):683-691. (Pubitemid 44902067)
6. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167.
7. Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing? Ann Surg Oncol. 2004;11(12):1093-1097. (Pubitemid 40486656)
8. Sprague BL, Warren Andersen S, Trentham-Dietz A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control. 2008;19(6):585-593.
9. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007; 177(11):1357-1361. (Pubitemid 350207190)
10. McNeil C. Annual cancer statistics report raises key questions. J Natl Cancer Inst. 2006;98(22):1598-1599.
11. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20-37. (Pubitemid 46143500)
12. McCoy KL, Jabbour N, Ogilvie JB, Ohori NP, Carty SE, Yim JH. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery. 2007;142(6):837-844; discussion 844 e831-833.
13. Frates MC, Benson CB, Doubilet PM, et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography. J Clin Endocrinol Metab. 2006;91(9):3411-3417. (Pubitemid 44402112)
14. Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy. J Ultrasound Med. 2004;23(11):1455-1464. (Pubitemid 39411250)
15. Paramo JC, Mesko T. Age, tumor size, and inoffice ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocr Pract. 2008;14(4):447-451.
16. Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol. 2005;12(1):81-89. (Pubitemid 40486645)
17. Bilimoria KY, BentremDJ, Ko CY, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007;246(3):375-381; discussion 381-374.
18. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. (Pubitemid 351521864)
19. Brown SR, Lee S, Brown TA, Waddell BE. Effect of race on thyroid cancer care in an equal access healthcare system. Am J Surg. 2010;199(5):685-689.
20. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78-93. (Pubitemid 38519418)
21. Miller BA, Scoppa SM, Feuer EJ. Racial/ ethnic patterns in lifetime and age-conditional risk estimates for selected cancers. Cancer. 2006;106(3):670-682. (Pubitemid 43157632)
22. Mulla ZD, Margo CE. Primary malignancies of the thyroid: epidemiologic analysis of the Florida Cancer Data System registry. Ann Epidemiol. 2000;10(1):24-30. (Pubitemid 30038215)
23. Haselkorn T, Stewart SL, Horn-Ross PL. Why are thyroid cancer rates so high in southeast asian women living in the United States? The bay area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2003;12(2):144-150. (Pubitemid 36194004)
24. Clark JR, Eski SJ, Freeman JL. Risk of malignancy in Filipinos with thyroid nodules-a matched pair analysis. Head Neck. 2006;28(5):427-431. (Pubitemid 43673077)
25. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001;93(5):745-750. (Pubitemid 32695128)
26. Belfiore A, La Rosa GL, La Porta GA, et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med. 1992;93(4): 363-369.
27. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164(6):658-661.
28. Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP. Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg. 1995;170(5):467-470.
29. Yu GP, Li JC, Branovan D, McCormick S, Schantz SP. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ ethnicity groups. Thyroid. 2010;20(5):465-473.
30. Mandelblatt JS, Yabroff KR, Kerner JF. Equitable access to cancer services: A review of barriers to quality care. Cancer. 1999; 86(11):2378-2390. (Pubitemid 30010381)
31. DeGroot LJ, Kaplan EL, Shukla MS, Salti G, Straus FH. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab. 1995;80(10):2946-2953.
32. Lang BH, Lo CY, Chan WF, Lam AK, Wan KY. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg. 2006;30(5):752-758. (Pubitemid 43724102)
33. Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab. 1997; 82(11):3553-3562. (Pubitemid 27509336)
34. Neff RL, Farrar WB, Kloos RT, Burman KD. Anaplastic thyroid cancer. Endocrinol Metab Clin North Am. 2008;37(2):525-538, xi. (Pubitemid 351711678)
35. Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab. 1999;84(11):4043-4049. (Pubitemid 30644192)